Medibio Limited
TrivarX Limited, a health technology company, engages in the development of AI-driven, scientifically-based devices for screening and diagnosis of behavioral health conditions in Australia and the United States. The company offers mental well-being solutions for businesses through corporate health product; and develops products for healthcare provider market. The company was formerly known as Med… Read more
Medibio Limited (MDBIF) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of June 2025: -0.042x
Based on the latest financial reports, Medibio Limited (MDBIF) has a cash flow conversion efficiency ratio of -0.042x as of June 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-525.45K) by net assets ($12.65 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Medibio Limited - Cash Flow Conversion Efficiency Trend (2001–2025)
This chart illustrates how Medibio Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Medibio Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Medibio Limited ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
CAMECO
MU:CJ6
|
0.008x |
|
Navkar Urbanstructure Limited
NSE:NAVKARURB
|
N/A |
|
IRSTF
OTCGREY:IRSTF
|
N/A |
|
Thai Mui Corporation Public Company Limited
BK:THMUI
|
0.015x |
|
GRENERGY RENOVALBL.EO-15
MU:5GR
|
N/A |
|
TOWER SEMICON INS (TOW.SG)
STU:TOW
|
0.045x |
|
Ceprocim SA
RO:CEPO
|
N/A |
|
Cosmo Metals Ltd
AU:CMO
|
0.000x |
Annual Cash Flow Conversion Efficiency for Medibio Limited (2001–2025)
The table below shows the annual cash flow conversion efficiency of Medibio Limited from 2001 to 2025.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-06-30 | $12.65 Million | $-161.65K | -0.013x | +91.43% |
| 2024-06-30 | $9.89 Million | $-1.48 Million | -0.149x | -1.51% |
| 2023-06-30 | $6.34 Million | $-932.08K | -0.147x | +37.06% |
| 2022-06-30 | $7.11 Million | $-1.66 Million | -0.233x | -125.45% |
| 2021-06-30 | $16.42 Million | $-1.70 Million | -0.104x | +63.55% |
| 2020-06-30 | $12.61 Million | $-3.58 Million | -0.284x | +64.08% |
| 2019-06-30 | $8.60 Million | $-6.80 Million | -0.791x | +9.22% |
| 2018-06-30 | $13.99 Million | $-12.18 Million | -0.871x | -113.78% |
| 2017-06-30 | $13.31 Million | $-5.42 Million | -0.407x | -28.14% |
| 2016-06-30 | $8.49 Million | $-2.70 Million | -0.318x | -91.22% |
| 2015-06-30 | $9.11 Million | $-1.52 Million | -0.166x | +26.27% |
| 2014-06-30 | $2.71 Million | $-611.26K | -0.226x | +51.35% |
| 2013-06-30 | $2.54 Million | $-1.18 Million | -0.464x | +25.11% |
| 2012-06-30 | $2.44 Million | $-1.51 Million | -0.619x | +80.13% |
| 2011-06-30 | $1.18 Million | $-3.67 Million | -3.115x | -30.81% |
| 2010-06-30 | $1.10 Million | $-2.61 Million | -2.381x | -185.48% |
| 2009-06-30 | $2.46 Million | $-2.05 Million | -0.834x | -145.46% |
| 2008-06-30 | $5.68 Million | $-1.93 Million | -0.340x | +35.54% |
| 2007-06-30 | $1.88 Million | $-992.15K | -0.527x | -45.53% |
| 2006-06-30 | $2.26 Million | $-818.20K | -0.362x | -61.21% |
| 2005-06-30 | $4.44 Million | $-997.01K | -0.225x | +0.97% |
| 2004-06-30 | $4.86 Million | $-1.10 Million | -0.227x | +64.67% |
| 2002-06-30 | $6.05 Million | $-3.89 Million | -0.642x | -147.49% |
| 2001-06-30 | $6.05 Million | $-1.57 Million | -0.260x | -- |